Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Phase 1 Withdrawn University of California, Irvine Beckman Laser Institute University of California Irvine · collab

RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to improve port wine stain therapeutic outcome in response to laser therapy. The researcher want to determine whether the combined use of pulsed dye laser therapy and topical ranibizumab will improve port wine stain therapeutic outcome.

Timeline

Start: 2008-03
Primary completion: 2013-11
Completion: 2013-11

Outcome

Outcome not reported

Stopped (Enrollment): “No participants enrolled”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ranibizumab	Monoclonal antibody	—	Topical

Indications

No indication recorded.